These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 32381577

  • 1. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia.
    D'Altri T, Wilhelmson AS, Schuster MB, Wenzel A, Kalvisa A, Pundhir S, Meldgaard Hansen A, Porse BT.
    Haematologica; 2021 Apr 01; 106(4):1000-1007. PubMed ID: 32381577
    [Abstract] [Full Text] [Related]

  • 2. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
    Asada S, Kitamura T.
    Int J Hematol; 2019 Aug 01; 110(2):179-186. PubMed ID: 30515738
    [Abstract] [Full Text] [Related]

  • 3. [Role of ASXL1 mutation in myeloid malignancies].
    Sheng MY, Zhou Y, Xu MJ, Yang FC.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug 01; 22(4):1183-7. PubMed ID: 25130853
    [Abstract] [Full Text] [Related]

  • 4. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
    Fujino T.
    Rinsho Ketsueki; 2022 Aug 01; 63(6):561-572. PubMed ID: 35831189
    [Abstract] [Full Text] [Related]

  • 5. The role of ASXL1 in hematopoiesis and myeloid malignancies.
    Asada S, Fujino T, Goyama S, Kitamura T.
    Cell Mol Life Sci; 2019 Jul 01; 76(13):2511-2523. PubMed ID: 30927018
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic regulation by ASXL1 in myeloid malignancies.
    Yang FC, Agosto-Peña J.
    Int J Hematol; 2023 Jun 01; 117(6):791-806. PubMed ID: 37062051
    [Abstract] [Full Text] [Related]

  • 7. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C, Burillo-Sanz S, Morales-Camacho RM, Pérez-López O, Suito M, Vargas MT, Caballero-Velázquez T, Carrillo-Cruz E, González J, Bernal R, Pérez-Simón JA.
    Cancer Med; 2020 Jun 01; 9(11):3637-3646. PubMed ID: 32216059
    [Abstract] [Full Text] [Related]

  • 8. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
    Gelsi-Boyer V, Brecqueville M, Devillier R, Murati A, Mozziconacci MJ, Birnbaum D.
    J Hematol Oncol; 2012 Mar 21; 5():12. PubMed ID: 22436456
    [Abstract] [Full Text] [Related]

  • 9. The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model.
    Hsu YC, Chiu YC, Lin CC, Kuo YY, Hou HA, Tzeng YS, Kao CJ, Chuang PH, Tseng MH, Hsiao TH, Chou WC, Tien HF.
    J Hematol Oncol; 2017 Jul 11; 10(1):139. PubMed ID: 28697759
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.
    Nagase R, Inoue D, Pastore A, Fujino T, Hou HA, Yamasaki N, Goyama S, Saika M, Kanai A, Sera Y, Horikawa S, Ota Y, Asada S, Hayashi Y, Kawabata KC, Takeda R, Tien HF, Honda H, Abdel-Wahab O, Kitamura T.
    J Exp Med; 2018 Jun 04; 215(6):1729-1747. PubMed ID: 29643185
    [Abstract] [Full Text] [Related]

  • 12. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
    Wang K, Zhou F, Cai X, Chao H, Zhang R, Chen S.
    Hematology; 2020 Dec 04; 25(1):211-218. PubMed ID: 32476595
    [Abstract] [Full Text] [Related]

  • 13. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.
    Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, Koche R, Shih AH, Guryanova OA, Kim E, Li S, Pandey S, Shin JY, Telis L, Liu J, Bhatt PK, Monette S, Zhao X, Mason CE, Park CY, Bernstein BE, Aifantis I, Levine RL.
    J Exp Med; 2013 Nov 18; 210(12):2641-59. PubMed ID: 24218140
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis.
    Zhang A, Wang S, Ren Q, Wang Y, Jiang Z.
    Asia Pac J Clin Oncol; 2023 Oct 18; 19(5):e183-e194. PubMed ID: 36471477
    [Abstract] [Full Text] [Related]

  • 15. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
    Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, Nguyen L, Yuan J, Jiang L, Yang X, Weeks O, Liu Z, Zhou J, Ni H, Cai CL, Xu M, Yang FC.
    Blood; 2014 Jan 23; 123(4):541-53. PubMed ID: 24255920
    [Abstract] [Full Text] [Related]

  • 16. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R, Mansat-De Mas V, Gelsi-Boyer V, Demur C, Murati A, Corre J, Prebet T, Bertoli S, Brecqueville M, Arnoulet C, Recher C, Vey N, Mozziconacci MJ, Delabesse E, Birnbaum D.
    Oncotarget; 2015 Apr 10; 6(10):8388-96. PubMed ID: 25860933
    [Abstract] [Full Text] [Related]

  • 17. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.
    Kanagal-Shamanna R, Luthra R, Yin CC, Patel KP, Takahashi K, Lu X, Lee J, Zhao C, Stingo F, Zuo Z, Routbort MJ, Singh RR, Fox P, Ravandi F, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE.
    Oncotarget; 2016 Mar 22; 7(12):14251-8. PubMed ID: 26883102
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations.
    Song J, Moscinski L, Yang E, Shao H, Hussaini M, Zhang H.
    In Vivo; 2023 Mar 22; 37(3):985-993. PubMed ID: 37103105
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.
    Johnson SM, Haberberger J, Galeotti J, Ramkissoon L, Coombs CC, Richardson DR, Foster MC, Duncan D, Montgomery ND, Ferguson NL, Zeidner JF.
    Leuk Lymphoma; 2024 Feb 22; 65(2):209-218. PubMed ID: 37921062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.